X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (333) 333
female (318) 318
adult (263) 263
hiv (244) 244
infectious diseases (221) 221
immunology (187) 187
middle aged (183) 183
women (157) 157
risk factors (132) 132
hiv infections - drug therapy (128) 128
human immunodeficiency virus--hiv (126) 126
aids (109) 109
cohort studies (107) 107
antiretroviral therapy (103) 103
hiv infection (103) 103
hiv infections - complications (102) 102
aids/hiv (88) 88
virology (86) 86
prospective studies (82) 82
cd4 lymphocyte count (79) 79
research (74) 74
male (72) 72
prevalence (71) 71
health aspects (70) 70
viral load (69) 69
antiretroviral therapy, highly active (67) 67
hiv infections - immunology (65) 65
human-immunodeficiency-virus (64) 64
virus diseases (64) 64
infection (62) 62
antiretroviral drugs (60) 60
hiv infections - virology (58) 58
mortality (57) 57
risk (53) 53
hiv infections - epidemiology (52) 52
disease progression (51) 51
public, environmental & occupational health (51) 51
drug therapy (50) 50
highly active antiretroviral therapy (50) 50
microbiology (50) 50
interagency hiv (49) 49
hiv patients (48) 48
united states - epidemiology (47) 47
active antiretroviral therapy (46) 46
epidemiology (45) 45
human immunodeficiency virus (45) 45
infections (43) 43
adolescent (41) 41
anti-hiv agents - therapeutic use (41) 41
cohort (41) 41
womens health (41) 41
aged (40) 40
cross-sectional studies (40) 40
acquired immune deficiency syndrome--aids (38) 38
longitudinal studies (37) 37
analysis (36) 36
disease (36) 36
young adult (36) 36
hiv-1 (35) 35
care and treatment (34) 34
united states (34) 34
association (33) 33
hiv infections - blood (33) 33
multivariate analysis (33) 33
medicine (31) 31
regression analysis (30) 30
viruses (30) 30
antiviral agents (29) 29
atherosclerosis (29) 29
hiv/aids (29) 29
medicine, general & internal (29) 29
risk-factors (29) 29
rna, viral - blood (29) 29
human papillomavirus (27) 27
proportional hazards models (27) 27
research article (27) 27
women's health (27) 27
inflammation (26) 26
united-states (26) 26
diagnosis (25) 25
hiv infections - mortality (25) 25
cd4 antigen (24) 24
hiv-1 - genetics (24) 24
science (24) 24
therapy (24) 24
adults (23) 23
cancer (23) 23
incidence (23) 23
usage (23) 23
acquired immune deficiency syndrome (22) 22
cervical cancer (22) 22
multidisciplinary sciences (22) 22
rna (22) 22
treatment outcome (22) 22
abridged index medicus (21) 21
complications and side effects (21) 21
individuals (21) 21
physiological aspects (21) 21
antiretroviral agents (20) 20
case-control studies (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, p. e0211099
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 5, p. e20183
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 11/2017, Volume 102, Issue 5, pp. 1173 - 1185
CXCR7 is expressed on CD14(+)CD16(+) monocytes in PBMC from uninfected and HIV infected individuals; CCX771 specifically blocks CXCL12-mediated transmigration... 
Human | monocytes | CCX771 | CD16 | CXCR4 | CD14 | Chemotaxis | RHEUMATOID-ARTHRITIS | IMMUNODEFICIENCY-VIRUS-INFECTION | ORPHAN RECEPTOR RDC1 | ANTIRETROVIRAL THERAPY | BETA-ARRESTIN | IMMUNOLOGY | CD14(+)CD16(-) monocytes | CELL BIOLOGY | CHEMOKINE RECEPTOR | NEUROCOGNITIVE DISORDERS | HEMATOLOGY | human | PREFERENTIALLY HARBORS HIV-1 | AIDS DEMENTIA | T-CELLS | chemotaxis | HIV Infections - prevention & control | Receptors, CXCR - immunology | Receptors, CXCR - antagonists & inhibitors | Humans | Middle Aged | Male | Monocytes - immunology | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Receptors, IgG - genetics | Cognitive Dysfunction - immunology | HIV-1 - growth & development | Blood-Brain Barrier - virology | Endothelial Cells - virology | Gene Expression | HIV Infections - virology | Lipopolysaccharide Receptors - immunology | Receptors, IgG - immunology | Transendothelial and Transepithelial Migration - immunology | Monocytes - drug effects | Blood-Brain Barrier - pathology | Monocytes - virology | Models, Biological | Transendothelial and Transepithelial Migration - genetics | Viral Load - drug effects | Immunologic Factors - pharmacology | GPI-Linked Proteins - genetics | Cognitive Dysfunction - prevention & control | Transendothelial and Transepithelial Migration - drug effects | Astrocytes - immunology | Adult | Female | CD4-Positive T-Lymphocytes - virology | Astrocytes - virology | Cognitive Dysfunction - drug therapy | Astrocytes - drug effects | Blood-Brain Barrier - immunology | GPI-Linked Proteins - immunology | Cognitive Dysfunction - virology | HIV-1 - drug effects | Receptors, CXCR - genetics | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | Endothelial Cells - immunology | Lipopolysaccharide Receptors - genetics | HIV Infections - drug therapy | Primary Cell Culture | CD4-Positive T-Lymphocytes - drug effects | Endothelial Cells - drug effects | Brain | CXCL12 protein | Disorders | Central nervous system | Cognitive ability | Cognition | Lymphocytes T | Inflammation | CD14 antigen | Antiretroviral therapy | Monocytes | CD16 antigen | Blood-brain barrier | Antiretroviral agents | Lymphocytes | Human immunodeficiency virus--HIV | Peripheral blood mononuclear cells | Chemokines | Cell migration
Journal Article
Journal Article
AIDS and Behavior, ISSN 1090-7165, 8/2018, Volume 22, Issue 8, pp. 2743 - 2755
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 4, p. e0195231
...Author(s): Jonathan Ross 1,*, Andrew Edmonds 2, Donald R. Hoover 3, Qiuhu Shi 4, Kathryn Anastos 1, Patricia Lelo 5, Frieda Behets 2, Marcel Yotebieng 6... 
SOUTH-AFRICA | RISK-FACTORS | POSTPARTUM WOMEN | MULTIDISCIPLINARY SCIENCES | RETROSPECTIVE COHORT | FOLLOW-UP | ANTIRETROVIRAL THERAPY | OPTION B PLUS | RANDOMIZED CONTROLLED-TRIAL | TO-CHILD TRANSMISSION | CONDITIONAL CASH TRANSFERS | Outcome Assessment (Health Care) | Pregnancy Complications, Infectious - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Kaplan-Meier Estimate | Socioeconomic Factors | Pregnancy | Young Adult | Public Health Surveillance | HIV Infections - diagnosis | Adolescent | Sex Factors | HIV Infections - therapy | Adult | Female | Disease Management | Retrospective Studies | Democratic Republic of the Congo | Delivery of Health Care - statistics & numerical data | Pregnancy Complications, Infectious - therapy | Pregnancy Complications, Infectious - diagnosis | Care and treatment | Pregnant women | Development and progression | Forecasts and trends | Medical statistics | HIV infection | Health aspects | Antiretroviral drugs | Hazards | Regression analysis | Medical diagnosis | Patients | Antiretroviral therapy | Postpartum | Regression models | Acquired immune deficiency syndrome--AIDS | Ross, Jonathan | Womens health | Antiretroviral agents | Human immunodeficiency virus--HIV | Health hazards | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 4, p. e0216049
...Author(s): Kerry Murphy 1, Marla J. Keller 1, Kathryn Anastos 1,2, Shada Sinclair 3, J. Cooper Devlin 4, Qiuhu Shi 5, Donald R. Hoover 6, Brian Starkman 7... 
TENOFOVIR DISOPROXIL FUMARATE | ACTIVATION | SECRETIONS | FEMALE GENITAL-TRACT | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | ACQUISITION | COMMUNITIES | TYPE-1 | ASSOCIATION | BACTERIAL VAGINOSIS | Premenopause | Humans | Middle Aged | Risk Factors | Solubility | Reproduction - physiology | HIV Infections - immunology | HIV Infections - microbiology | Microbiota | Aging - physiology | Vaginal Douching | Vaginosis, Bacterial - microbiology | Postmenopause | Adult | Female | Lactobacillus - physiology | Vagina - microbiology | Escherichia coli - physiology | Reproductive health | Microbiota (Symbiotic organisms) | Menopause | Physiological aspects | Vagina | Aging | HIV infection | Health aspects | Risk factors | Fibronectins | Women | RNA | Escherichia coli | Lactoferrins | Postmenopausal women | HIV (Viruses) | Protease inhibitors | Proteases | Comparative analysis | Enzyme-linked immunosorbent assay | Pediatrics | Antimicrobial activity | Mucosal immunity | Genital tract | rRNA 16S | Interleukin | Microbiomes | Risk | Infections | Immunity | Fibronectin | Reproductive status | Lactoferrin | E coli | Human immunodeficiency virus--HIV | Interleukin 8 | Antiretroviral drugs | Cytokines | Lactobacilli | Gynecology | Health risks | Risk reduction | Antimicrobial agents | Inflammation | Proteinase inhibitors | Obstetrics | Bactericidal activity | Antiretroviral therapy | Post-menopause | Medicine | White blood cells | Disease transmission | Defensins | Womens health | Herpes viruses | Risk management | HIV | Human immunodeficiency virus
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 2012, Volume 206, Issue 9, pp. 1453 - 1461
Journal Article